SCHEMBL4786223

SCHEMBL4786223

Cc1nc(-c2cccc(Cl)c2)n(C)c1C(=O)NC(=N)N

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.46
KMT2A Q03164 1/20 0.39
GRM5 P41594 2/20 0.39
SLC9A1 P19634 2/20 0.38
CNR2 P34972 3/20 0.38
HSD11B1 P28845 1/20 0.37
JAK2 O60674 1/20 0.37
IKBKB O14920 1/20 0.37
PIN1 Q13526 1/20 0.37
GABRA2 P47869 1/20 0.36
GABRB2 P47870 1/20 0.36
ADORA2A P29274 2/20 0.36
ADORA1 P30542 2/20 0.36
ADORA3 P0DMS8 1/20 0.36
ADORA2B P29275 1/20 0.36
CDC25A P30304 1/20 0.36
CDC25B P30305 1/20 0.36
KDM4E B2RXH2 1/20 0.36
LMNA P02545 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4784399 0.89 RAB9A (0.38) SLC9A1PIN1ADORA2AADORA1ALDH1A1
SCHEMBL4787618 0.85 CYP1A2 (0.47) KMT2AADORA2AADORA2BKDM4EALDH1A1
SCHEMBL4786802 0.83 ALDH1A1 (0.47) CNR2KDM4EHTTALDH1A1
SCHEMBL28746545 0.80 MAOB (0.50) MAOBKMT2AHSD11B1PIN1GABRA2
SCHEMBL4788478 0.79 HSD11B1 (0.42) CNR2HSD11B1ADORA2AADORA1LMNA
SCHEMBL4786226 0.79 SLC9A1 (0.52) MAOBSLC9A1
SCHEMBL4787412 0.73 TP53 (0.49) KMT2AHTTALDH1A1
SCHEMBL8703819 0.70 KAT6A (0.53) KDM4EALDH1A1
SCHEMBL28746479 0.70 F11 (0.66) KMT2APIN1KDM4ELMNAHTT
SCHEMBL29565494 0.70 F11 (0.66) KMT2APIN1KDM4ELMNAHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008111794-A1 4-METHYLIMIDAZOL-5-YLCARBONYLGUANIDINE DERIVATIVES, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PREPARATION METHOD, AND PHARMACEUTICAL COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF THE ISCHEMIC HEART DISEASES CONTAINING THE SAME AS AN ACTIVE INGREDIENT KOREA RESERACH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2008-09-18 WO disclosed